1Moran CA, Suster S. Thymic carcinoma: current concepts and histologic features[J]. Hematol Oncol Clin North Am, 2008,22(3) :393-407.
2Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients[J]. Cancer, 2002, 94 (3) ;624-632.
3Rena O, Papalia E, Maggi G, et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas [J]. Lung Cancer, 2005,50(1) ;59-66.
4Rea F, Marulli G, Girardi R, et al. Long-term survival and prognostic factors in thymic epithelial tumours[J]. Eur J Cardiothorac Surg, 2004,26 (2) : 412-418.
5Chen G, Marx A, Wen-Hu C, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China[J]. Cancer, 2002,95(2) :420- 429.
6Park MS, Chung KY, Kim KD, et al. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification [J]. Ann Thorac Surg, 2004,78 (3);992-997. discussion 997- 998.
7Okumura M, Miyoshi S, Fujii Y, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors[J]. Am J Surg Pathol, 2001,25(1): 103-110.
8Ayahe T, Matsuzaki Y, Edagawa M, et al. Surgery for the thymoma combined with pure red cell aplasia and myasthenia gravis [J]. Kyohu Geka, 2005, 58 (12) :1023-9; discussion 1029-1031.
9Kondo K, Monden Y. Thymoma and myasthenia gravis: a clinical study of 1089 patients from Japan[J]. Ann Thorac Surg, 2005,79(1) :219-224.
10Muller-Hermelink HK, Wilisch A, Schultz A, et al. Characterization of the human thymic microenvironment: lymphoepithelial interaction in normal thymus and thymoma[J]. Arch Histol Cytol, 1997,60(1):9- 28.
二级参考文献34
1Rosai J, Sobin LH. Histological typing of tumors of the thymus. In: World Health Organization, International Histologic al Classification of Tumors [M]. Berlin and Heidelberg:Springer-Verlag. 1999 :9-15.
2Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to the clinical stages[J].Cancer, 1981,48: 2455-2492.
3Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and noninvasive thymomas [J]. Pathol Int, 1994,45:87-89.
4Tsuchiya R, Koga K, Matsuno Y, et al. Thymic carcinoma:proposal for pathological TNM and staging[J]. Pathol Int,1994,44:505-512.
5Mangi AA, Wright C, Allan J, et al. Adjuvant radiation for stage Ⅱ thymomas[J]. Ann Thorac Surg 2002,74:1033-1037.
6Ogawa K, Uno T, Onishi H, et al. Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients[J]. Cancer,2002,94: 1405-1413.
7Myojin M, Choi N, Wright C, et al. Stage Ⅲ thymomas:pattern of failure after surgery and postoperative radiotherapy and its implication for future study[J]. Int J Radio Oncol Biol Phys,2000,46:927-933.
8Matsushima S, Yamamoto H, Egami K, et al. Evaluation of the prognostic factors after thymoma resection[J]. Int Surg,2001,86 : 103-106.
9Berruti A, Borasio P, Gerbino A, et al. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience[J]. Br J Cancer,1999, 81 :841-845.
10Shin DM, Walsh GL, Komaki R, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma[J].Ann Intern Med,1998, 129 :100-104.
